Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:42:20.647Z.
Calculation as of: 2026-10-06T13:42:20.647Z.
Quote observation: 2026-10-06T13:32:38.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$50.67M
Free Cash Flow Yield
38.84%
TTM Avg
42.72%
3Y Avg
26.54%
5Y Avg
31.80%
Market Cap
$52.80M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| eXoZymes, Inc. (EXOZ) | $51.23M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.71M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.67M | 38.84% | 42.72% | 26.54% | 31.80% |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.37M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.84M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.99M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
